ORIGINAL RESEARCH

Efficiency of the gynecologic malignancies identification measures at the level of primary health care

Bochkova AG, Domozhirova AS, Aksenovа IA1,3
About authors

1 South Ural State Medical University, Chelyabinsk, Russia

2 Russian Scientific Center for Roentgenoradiology, Moscow, Russia

3 Clinical Center of Oncology and Nuclear Medicine of Chelyabinsk Region, Chelyabinsk, Russia

Correspondence should be addressed: Anna G. Bochkova
Dovatora, 23, Chelyabinsk, 454091; ur.liam@6947avokhcobanna

About paper

Author contribution: Bochkova AG — research planning, manuscript writing, data acquisition, data analysis and interpretation, literature analysis; Domozhirova AS — research planning, data analysis and interpretation, manuscript editing; Aksenovа IA — data acquisition, manuscript writing.

Received: 2019-12-23 Accepted: 2020-01-08 Published online: 2020-01-23
|
  1. Sushinskaya TV, Zhordania KI, Payanidi YuG. Analiticheskie aspekty onkologicheskikh zabolevaniy zhenskogo naseleniya Rossii. Onkoginekologiya. 2015; (3): 40–3. Russian.
  2. Global Cancer Facts & Figures. 3rd edition. Atlanta, Georgia: American Cancer Society. 2015; 61 p.
  3. Kaprin AD, Starinskiy VV, Petrova GV, redaktory. Zlokachestvennye novoobrazovaniya v Rossii v 2017 godu (zabolevaemost' i smertnost'). M.: MNIOI im. P.A. Gertsena — filial FGBU «NMIСradiologii» Minzdrava Rossii, 2018; 250 s. Russian.
  4. Aleksandrova LM, Starinskiy VV, Kaprin AD, Samsonov YuV. Profilaktika onkologicheskikh zabolevaniy kak osnova vzaimodeystviya onkologicheskoy sluzhby s pervichnym zvenom zdravookhraneniya. Issledovaniya i praktika v meditsine. 2017; (4): 74–80. Russian.
  5. Moshurov IP, Kravets BB, Korotkikh NV. Organizatsionnye rezervy snizheniya smertnosti ot raka sheyki matki. Onkoginekologiya. 2014; (4): 28–33. Russian.
  6. Krivonos OV, Chissov VI, Starinskiy VV, Aleksandrova LM. Rol'i zadachi smotrovogo kabineta polikliniki kak etapa v organizatsii profilakticheskikh meropriyatiy, napravlennykh na sovershenstvovanie onkologicheskoy pomoshchi naseleniyu: metodicheskie rekomendatsii. M., 2010. Available from: http:// www.oncology.ru/service/organization/exam_room.pdf (data obrascheniya: 10.11.2019). Russian.
  7. Domozhirova AS, Vazhenin AV. Vtorichnaya profilaktika raka v sisteme regional'nogo zdravookhraneniya. M.: Izd-vo RAMN, 2012; 192 s. Russian.
  8. Shubin BM, Vinokur ML, Popova AA. Vyyavlenie opukholevykh zabolevaniy v smotrovom kabinete. Leningrad: Meditsina, 1980; 208 s. Russian.
  9. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol. 2012; 120 (5): 1222–38.
  10. Ronco G, Anttila A. Cervical cancer screening in Europe — changes over the last 9 years. Eur J Cancer. 2009; 45 (15): 2629–31. DOI: 10.1016/j.ejca.2009.07.021.
  11. Petrova GV, Grecova OP, Kaprin AD, Starinskij VV. Harakteristika i metody rascheta mediko-statisticheskih pokazatelej, primenyaemyh v onkologii. M.: FGBU MNIOI im. P.A. Gercena Minzdrava RF, 2014; 40 s.
  12. Merabishvili VM. Onkologicheskaya statistika (tradicionnye metody, novye informacionnye tekhnologii): Rukovodstvo dlya vrachej. Izd. 2-e, dop. SPb., 2015; 248 s.
  13. Merabishvili VM. Vyzhivaemost' onkologicheskih bol'nyh. SPb., 2011; 329 s.
  14. Urmancheeva AF, Kutusheva GF, Ul'rih EA. Opuholi yaichnika (klinika, diagnostika i lechenie). SPb.: Izd-vo N-L, 2012; 68 s.
  15. Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016; 387 (10022): 945–56. PubMed PMID: 26707054.
  16. Johnson N. Two large randomised trials show ovarian cancer screening has minimal impact on survival. BJOG. 2016; 125 (5): 524–5.
  17. Kaprin AD, Starinskij VV, Petrova GV, redaktory. Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2017 godu. M.: MNIOI im. P.A. Gercena – filial FGBU «NMICradiologii» Minzdrava Rossii, 2018; 236 s.
  18. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD. Available from: https://seer.cancer.gov/ csr/1975_2016/sections.html.